Facebook post by University of Helsinki

Although we know that diseases, drugs and treatments affect different sexes differently, the underlying reasons are poorly understood. Dr. Taru Tukiainen explores the biology underlying the male-female differences in disease risk and outcome. She wants to: - improve current risk prediction models - facilitate more accurate treatment and intervention Improved sex-specific diagnostics and treatments contribute to better gender equality in the healthcare sector.
Why has sex been overlooked in biomedical research? | University of Helsinki helsinki.fi

The genomicist Taru Tukiainen explores the poorly understood sex differences in human health and disease to improve current risk prediction models and to facilitate more accurate treatment and intervention.